Consun Pharmaceutical Group Limited announced that Ms. CHENG Xinxin ("Ms. Cheng") has resigned from the position of an independent non-executive Director, the chairlady of the audit committee (the "Audit Committee") and a member of the nomination committee (the "Nomination Committee") of the Company with effect upon the conclusion of the upcoming annual general meeting of the Company (the "AGM"), which is expected to be held on 31 May 2019, in order to devote more time to her family. Ms. Cheng has confirmed that she has no claim whatsoever against the Company for fees, compensation for loss of office, remuneration, severance payments, pension, expenses or otherwise and has no disagreement with the Board and there is no matter relating to her resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") or the shareholders of the Company (the "Shareholders").

The Board proposed to declare a final dividend of HKD 0.20 per ordinary share of the company ("Final Dividend"). Subject to approval by the Shareholders at the AGM, the proposed final dividend was initially expected to be paid on or about 17 June 2019 to Shareholders whose name appear on the registered of members of the Company on 10 June 2019. Record date is 14 June 2019.